VeriMomDois-je éviter cannabidiol - synthetically produced pendant la grossesse ? | VeriMom
Evidence from animal and human-relevant studies shows cannabidiol (CAS 13956-29-1) transfers to the fetus and accumulates in fetal tissues in rodent models, and authorities have raised reproductive concerns (ANSES proposal and multiple C&L notifications listing H361), so reproductive hazard is 'suspected' rather than confirmed. SCCS evaluated CBD for cosmetic use and provided a dermal safe limit (0.19%), indicating risk is dose/exposure dependent; dermal absorption is measurable at cosmetic use levels. Sources: SCCS opinion, rodent PK study, ANSES position, ECHA C&L notifications.
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- cannabidiol - synthetically produced est-il sûr pendant la grossesse ?
- Evidence from animal and human-relevant studies shows cannabidiol (CAS 13956-29-1) transfers to the fetus and accumulates in fetal tissues in rodent models, and authorities have raised reproductive concerns (ANSES proposal and multiple C&L notifications listing H361), so reproductive hazard is 'suspected' rather than confirmed. SCCS evaluated CBD for cosmetic use and provided a dermal safe limit (0.19%), indicating risk is dose/exposure dependent; dermal absorption is measurable at cosmetic use levels. Sources: SCCS opinion, rodent PK study, ANSES position, ECHA C&L notifications.
- cannabidiol - synthetically produced est-il sûr pendant l'allaitement ?
- Regulatory and public-health authorities advise against CBD use while breastfeeding because cannabinoids can be transferred to infants (authoritative guidance from FDA and reviews), and animal data show developmental effects; mechanism evidence includes demonstrated maternal–infant transfer and pharmacologic activity in offspring. Measured systemic exposure after dermal use is generally low but nonzero, so breastmilk exposure from topical products is plausible at higher maternal systemic levels.
- cannabidiol - synthetically produced est-il sûr pour la peau de bébé ?
- Do not increase hazard/mechanism without infant-specific data, but increase exposure score for infant skin because infant epidermal barrier immaturity and higher surface-area-to-weight make absorption relatively greater. Given demonstrated maternal–fetal transfer and animal developmental effects, CBD remains a suspected reproductive/developmental hazard for infants if systemic exposure occurs.
- Comment VeriMom évalue-t-il cannabidiol - synthetically produced ?
- VeriMom évalue cannabidiol - synthetically produced à 20/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à cannabidiol - synthetically produced pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à cannabidiol - synthetically produced basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.